LGC to Market Gentris' GentriSure Controls in Europe, Asia | GenomeWeb
NEW YORK (GenomeWeb News) — Gentris today said that London-based reference materials company LGC Promochem will market its GentriSure products to labs in Europe and India.
Gentris, a genotyping products and services company based in Morrisville, NC, said the human genomic reference controls now contain polymorphisms for the CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes. The firm added that they are derived from human donors and do not include artificial DNA sequences.   

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.